Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Joint project of Lukoil and Gazprom hit by sanctions

1/10/25 LKOH

Gazprom Shelfproject and RusGazAlliance are on the sanctions list

1/10/25 GAZP

Polar Lithium has fallen under sanctions

1/10/25 GMKN

Gazprom's LNG plant on the Baltic Sea hit by sanctions

1/10/25 GAZP

USA extends sanctions against Arctic LNG 2

1/10/25 NVTK

Sovcomflot vessels hit by sanctions

1/10/25 FLOT

US imposed sanctions on Gazprom Neft's subsidiaries

1/10/25 SIBN

USA imposed sanctions against Surgutneftegaz

1/10/25 SNGS

Vostok Oil fell under US sanctions

1/10/25 ROSN

Lukoil may receive about $ 4.3 billion for the sale of its assets in Bulgaria

1/10/25 LKOH